NDAINHALATIONLIQUID
Approved
Jun 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ULTANE (sevoflurane) by AbbVie. Approved for anesthesia, general anesthesia. First approved in 1995.
Drug data last refreshed 18h ago
Mechanism of Action
Pharmacologic Class:
General Anesthetic
Indications (2)
Clinical Trials (20)
Does Boredom With Simultaneously Perceived Pain Affect Pressure Pain Thresholds
Started Jan 2026
161 enrolled
Pain Thresholds
Sevoflurane Sedation in Patients With Septic Shock
Started Jan 2026
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
Started Oct 2025
156 enrolled
Locally Advanced Rectal Adenocarcinoma
Assessment of Hard and Soft Tissue Changes Following XCM Versus FGG Simultaneous With Delayed Dental Implant Placement
Started Sep 2025
24 enrolled
Missing Teeth
Use of Sevoflurane to Test Concept of Cognitive Reserve
Started Sep 2024
70 enrolled
Cognitive ReserveBIS
Worked on ULTANE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.